Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease
Objective: This study aims to investigate the clinical efficacy of Ganshuang granules combined with tenofovir, an antiviral drug, in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease.Methods: A total of 92 patients with chronic hepatitis B combined with non-alcoh...
Main Authors: | Changtian Su, Qin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1032789/full |
Similar Items
-
Research progress of the impact of nonalcoholic fatty liver disease on chronic hepatitis B infection
by: BENEDICK Jun Er Chin, et al.
Published: (2023-12-01) -
Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01) -
Obesity and nonalcoholic fatty liver disease: current perspectives
by: Sarwar R, et al.
Published: (2018-09-01) -
Integrative proteomics and metabolomics explore the effect and mechanism of Qiyin granules on improving nonalcoholic fatty liver disease
by: Xuehua Yan, et al.
Published: (2024-03-01) -
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
by: Giovanni Tarantino, et al.
Published: (2024-02-01)